This increases m6A marks in the 3′UTR of GATA3 pre-mRNA that prevent binding of HuR (Figure 1), promote RNA degradation, reduce GATA3 levels and help HCC proliferation and metastasis. The gene discussed is ELAVL1; the disease is hepatocellular carcinoma.